Balyasny Asset Management »

Cerevel Therapeutics Hldng I shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $95M 2.2M 42.40
2023-09-30 $650k 30k 21.83
2023-06-30 $3.5M 111k 31.79
2023-03-31 $8.5M 350k 24.39

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Financial (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Hess Put Option (HES)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
JPMorgan Chase & Co. Call Option (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Union Pacific Corporation Call Option (UNP)
Select Sector Spdr Tr Technology (XLK)
Boeing Company (BA)
Deere & Company (DE)

View all positions for Balyasny Asset Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I